Stable allosteric binding of m1-toxin to m1 muscarinic receptors
- PMID: 8264554
Stable allosteric binding of m1-toxin to m1 muscarinic receptors
Abstract
m1-Toxin was found to slow the dissociation of [3H]N-methyl-scopolamine (NMS) and [3H]pirenzepine from m1 muscarinic receptors expressed in the membranes of Chinese hamster ovary cells. When toxin-NMS-receptor complexes were formed in membranes and then dissolved in digitonin, or when these complexes were formed in solution, the toxin completely stopped the dissociation of [3H]NMS for 6 hr at 25 degrees C. Toxin-receptor complexes formed in membranes or in solution were also highly stable in solution at 25 degrees, as shown by the ability of the toxin to prevent the binding of [3H]quinuclidinyl benzilate (QNB). [3H] QNB-receptor complexes were equally stable, whereas unliganded soluble receptors lost most of their ability to bind QNB within an hour. Toxin-receptor complexes could be partially dissociated by incubation at 37 degrees in the presence of digitonin and [3H]QNB, and the freed receptors were then labeled. These results demonstrate that m1-toxin binds allosterically and pseudoirreversibly to m1 receptors, and that the toxin can stabilize the outward-facing pocket of m1 receptors which contains and binds competitive antagonists. The allosteric nature of the binding of m1-toxin should prove to be useful for such unusual purposes as stabilizing the binding of readily reversible and/or nonselective ligands specifically to m1 receptors, for purifying labeled or unlabeled receptors by affinity techniques which recognize the toxin, for recognizing receptors with genetically or biochemically altered primary binding sites, and for stabilization of the native conformation of m1 receptors for structural studies.
Similar articles
-
Use of m1-toxin as a selective antagonist of m1 muscarinic receptors.J Pharmacol Exp Ther. 1993 Oct;267(1):480-5. J Pharmacol Exp Ther. 1993. PMID: 8229778
-
Site-directed mutagenesis of m1-toxin1: two amino acids responsible for stable toxin binding to M(1) muscarinic receptors.Mol Pharmacol. 2001 Oct;60(4):725-31. Mol Pharmacol. 2001. PMID: 11562434
-
Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.J Pharmacol Exp Ther. 1995 Sep;274(3):1077-83. J Pharmacol Exp Ther. 1995. PMID: 7562472
-
The pharmacological action of MT-7.Life Sci. 2005 Feb 18;76(14):1547-52. doi: 10.1016/j.lfs.2004.10.029. Epub 2004 Dec 18. Life Sci. 2005. PMID: 15680165 Review.
-
m1-toxin.Life Sci. 1993;52(5-6):433-40. doi: 10.1016/0024-3205(93)90299-i. Life Sci. 1993. PMID: 8441325 Review.
Cited by
-
Inactive structures of the vasopressin V2 receptor reveal distinct binding modes for Tolvaptan and Mambaquaretin toxin.Nat Commun. 2025 Apr 24;16(1):3899. doi: 10.1038/s41467-025-59114-5. Nat Commun. 2025. PMID: 40274867 Free PMC article.
-
Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells.Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11465-70. doi: 10.1073/pnas.95.19.11465. Proc Natl Acad Sci U S A. 1998. PMID: 9736760 Free PMC article.
-
Adrenoceptor activity of muscarinic toxins identified from mamba venoms.Br J Pharmacol. 2011 Sep;164(2b):538-50. doi: 10.1111/j.1476-5381.2011.01468.x. Br J Pharmacol. 2011. PMID: 21557730 Free PMC article.
-
Structure and selectivity engineering of the M1 muscarinic receptor toxin complex.Science. 2020 Jul 10;369(6500):161-167. doi: 10.1126/science.aax2517. Science. 2020. PMID: 32646996 Free PMC article.
-
Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).Br J Pharmacol. 2000 Oct;131(3):447-52. doi: 10.1038/sj.bjp.0703606. Br J Pharmacol. 2000. PMID: 11015294 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources